Cis- and Trans-Palmitoleic Acid Isomers Regulate Cholesterol Metabolism in Different Ways
Open Access
- 8 December 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11
Abstract
Hypercholesterolemia is a preventable risk factor for atherosclerosis and cardiovascular disease. However, the mechanisms wherebycis-palmitoleic acid (cPOA) andtrans-palmitoleic acid (tPOA) promote cholesterol homeostasis and ameliorate hypercholesterolemia remain elusive. To investigate the effects ofcPOA andtPOA on cholesterol metabolism and its mechanisms, we induced hypercholesterolemia in mice using a high-fat diet and then intragastrically administeredcPOA ortPOA once daily for 4 weeks.tPOA administration reduced serum cholesterol, low-density lipoprotein, high-density lipoprotein, and hepatic free cholesterol and total bile acids (TBAs). Conversely,cPOA had no effect on these parameters except for TBAs. Histological examination of the liver, however, revealed thatcPOA ameliorated hepatic steatosis more effectively thantPOA.tPOA significantly reduced the expression of 3-hydroxy-3-methyl glutaryl coenzyme reductase (HMGCR), LXRα, and intestinal Niemann-Pick C1-Like 1 (NPC1L1) and increased cholesterol 7-alpha hydroxylase (CYP7A1) in the liver, whereascPOA reduced the expression of HMGCR and CYP7A1 in the liver and had no effect on intestinal NPC1L1. In summary, our results suggest thatcPOA andtPOA reduce cholesterol synthesis by decreasing HMGCR levels. Furthermore,tPOA, but notcPOA, inhibited intestinal cholesterol absorption by downregulating NPC1L1. Both high-dosetPOA andcPOA may promote the conversion of cholesterol into bile acids by upregulating CYP7A1.tPOA andcPOA prevent hypercholesterolemia via distinct mechanisms.Keywords
Funding Information
- State Oceanic Administration, Ministry of Natural Resources (2016040)
- National Natural Science Foundation of China (81870138)
This publication has 41 references indexed in Scilit:
- Plasma Phospholipid Concentration of Cis -Palmitoleic Acid and Risk of Heart FailureCirculation: Heart Failure, 2012
- Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestineJournal of Lipid Research, 2012
- The N-terminal Domain of NPC1L1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol UptakeJournal of Biological Chemistry, 2011
- Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetesThe American Journal of Clinical Nutrition, 2010
- The structure and function of Niemann–Pick C1-like 1 proteinCurrent Opinion in Lipidology, 2008
- The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1Cell Metabolism, 2008
- Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibeJournal of Clinical Investigation, 2007
- Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol HomeostasisJournal of Biological Chemistry, 2004
- The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoterJournal of Lipid Research, 2004
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004